Close
Wonach suchen Sie?
Site search
Suchfilter

Best Lawyers Switzerland 2025

Recommended in Information Technology Law, Media Law, Technology Law, Telecommunications Law

Best Lawyers Switzerland 2025

Lawyer of the year

Best Lawyers Switzerland 2015 - 2023

Recommended for Entertainmend Law, Information Technology Law, Intellectual Property Law - Copyright, Media Law, Technology Law, Telecommunications Law.

Lawyer of the year 2015, 2018, 2019, 2021 and 2023

Best Lawyers Switzerland 2010 - 2023

Recommended for Information Technoloigy Law, Media Law, Technology Law, Telecommunications Law

Legal 500 (EMEA 2022) – "TMT"

"David Rosenthal is a leader in the area of data protection. He has significant experience in the application of data protection implication in the litigation and investigation context. David Rosenthal provides valuable practical advice to navigate cooperations through the issue of cross-border transfers."

Who's Who Legal (Global 2020) - "Data - Information Technology"

Recommended for Data - Information Technology

Who's Who Legal Thought Leaders (Global 2020) - "Data - Telecoms & Media"

"Rolf Auf der Maur is commended for his considerable experience handling mergers and acquisitions and related regulatory matters for clients in the media and telecoms space." He is listed as Global Elite Thought Leader.

Who's Who Legal Thought Leaders (Global 2020) - "Data - Information Technology"

"Rolf Auf der Maur, a standout expert in data matters who represents various clients in issues such as internet rights, compliance and regulatory regimes."

Who's Who Legal Thought Leaders (Switzerland 2020) - "Patents"

"Stefan Kohler possesses strong experience in IP and technology law, and is active in a plethora of industries including biotech, cosmetics and healthcare."

Who's Who Legal Thought Leaders (Switzerland 2020) - "Life Sciences"

"Stefan Kohler is a standout lawyer distinguished for his expertise in IP law. He brings significant value to clients due to his insights into the biotech, healthcare and pharma markets."